Cancer can coaptate the immune control of the immune system (IS), evade immunity and its destruction.
So, could we say openly that immunotherapy is a viable treatment option for patients with advanced
cancer? Yes, immunotherapy would give us great advances in the war against cancer. Therefore, the
development of a new generation of immune modulators (which have been analyzed in the following
article) is necessary. In addition, these will be more effective if we use them in combination, taking
advantage of their synergy.Universidad de Málaga. Campus de Excelencia Internacional Andalucía Tech
